{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T02:00:06Z","timestamp":1783216806712,"version":"3.54.6"},"publisher-location":"New York, NY","reference-count":40,"publisher":"Springer New York","isbn-type":[{"value":"9781493987955","type":"print"},{"value":"9781493987962","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-1-4939-8796-2_9","type":"book-chapter","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T16:59:43Z","timestamp":1549472383000},"page":"95-105","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Clinical Studies of Methionine-Restricted Diets for Cancer Patients"],"prefix":"10.1007","author":[{"given":"Robert M.","family":"Hoffman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,7]]},"reference":[{"key":"9_CR1","first-page":"112","volume":"77","author":"N Goseki","year":"1980","unstructured":"Goseki N, Mori S, Habu H, Menjyo M, Murakami T (1980) Effect of intravenous methionine free hyperalimentation combined with anti-cancer drugs (RT-therapy) on adenocarcinoma of gastrointestinal tract. Jpn J Gastroenterol 77:112","journal-title":"Jpn J Gastroenterol"},{"key":"9_CR2","first-page":"1908","volume":"17","author":"N Goseki","year":"1987","unstructured":"Goseki N, Onodera T, Mori S, Menjyo M (1987) Clinical study of amino acid imbalance as an adjunct to cancer therapy. J Jpn Soc Cancer Ther 17:1908\u20131916","journal-title":"J Jpn Soc Cancer Ther"},{"key":"9_CR3","first-page":"343","volume-title":"Parenteral and enteral hyperalimentation","author":"N Goseki","year":"1984","unstructured":"Goseki N, Onodera T, Kosaki G, Tsuruta K, Mori S, Tsukada K (1984) Methionine and cysteine free amino acid imbalance by total parenteral nutrition as an adjunct to cancer chemotherapy. In: Ogoshi S, Okada A (eds) Parenteral and enteral hyperalimentation. Elsevier, Amsterdam, pp 343\u2013355"},{"key":"9_CR4","unstructured":"Goseki N, Onodera T, Tominaga T, Kosaki G, Koike M. (1985) Inhibitory effect of methionine deprived total parenteral nutrition combines with acinomycin-D on rat experimental tumors. Proc 14th Int Congr Chemother, 438\u2013439"},{"key":"9_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1620\/tjem.151.191","volume":"151","author":"N Goseki","year":"1987","unstructured":"Goseki N, Onodera T, Koike M, Kosaki G (1987) Inhibitory effect of L-methionine deprived amino acid imbalance using total parenteral nutrition on growth of ascites hepatoma in rats. Tohoku J Exp Med 151:191\u2013200","journal-title":"Tohoku J Exp Med"},{"key":"9_CR6","first-page":"99","volume":"20","author":"N Goseki","year":"1987","unstructured":"Goseki N, Yamazaki S, Toyoda T, Endo M, Tsukada K, Onodera T, Kosaki G, Koike M, Satou H (1987) Cancer therapy by methionine deprived total parenteral nutrition with mitomycin C and\/or 5-fluorouracil. Oncologia 20:99\u2013110","journal-title":"Oncologia"},{"key":"9_CR7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1620\/tjem.157.251","volume":"157","author":"N Goseki","year":"1989","unstructured":"Goseki N, Endo M, Onodera T, Kosaki G (1989) Influence of L-methionine-deprived total parenteral nutrition on the tumor and plasma amino acids fraction and host metabolism. Tohoku J Exp Med 157:251\u2013260","journal-title":"Tohoku J Exp Med"},{"key":"9_CR8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1620\/tjem.161.227","volume":"161","author":"N Goseki","year":"1990","unstructured":"Goseki N, Endo M (1990) Thiol depletion and chemosensitization on nimustine hydrochloride by methionine-deprived total parenteral nutrition \u2013 experimental studies on Sato lung carcinoma bearing rats. Tohoku J Exp Med 161:227\u2013239","journal-title":"Tohoku J Exp Med"},{"key":"9_CR9","first-page":"83","volume":"213","author":"N Goseki","year":"1991","unstructured":"Goseki N, Endo M, Onodera T, Kosaki G (1991) Antitumor effect of methionine-deprived total parenteral nutrition with 5-fluorouracil administration on Yoshida sarcoma-bearing rats. Ann Surg 213:83\u201388","journal-title":"Ann Surg"},{"key":"9_CR10","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1002\/1097-0142(19920401)69:7<1865::AID-CNCR2820690732>3.0.CO;2-M","volume":"69","author":"N Goseki","year":"1982","unstructured":"Goseki N, Yamazaki S, Endo M, Onodera T, Kosaki G, Hibino Y, Kuwahata T (1982) Antitumor effect of methionine-depleting total parenteral nutrition with doxorubicin administration on Yoshida sarcoma-bearing rats. Cancer 69:1865\u20131872","journal-title":"Cancer"},{"key":"9_CR11","first-page":"2405","volume":"17","author":"K Sugihara","year":"1990","unstructured":"Sugihara K, Goseki N, Yamazaki S, Endo M, Onodera T, Kosaki G, Mori S, Taguchi T, Kurihara M (1990) Early phase II study of the combined use of AO-90 methionine-free amino acid solution and anticancer agents (5-FU and MMC) in patients with advanced and recurrent gastrointestinal cancer. Jpn J Cancer Chemother 17:2405\u20132413","journal-title":"Jpn J Cancer Chemother"},{"key":"9_CR12","unstructured":"Taguchi T, Kosaki G, Onodera T, Endo M, Nakagawara Y, Kano K Kaibara N, Kakegawa T, Nakano S, Kurihara M, Akazawa S, Oota J, Kitamura M, Goseki N, Tokunaga K (1995) A controlled study of AO-90, a methionine-free amino acid solution, in advanced gastric cancer patients (surgery group evaluation). Jpn J Cancer Chemother in combination with 5-fluorouracil and mitomycin C. 22:753\u2013764 (in Japanese with English abstract)"},{"key":"9_CR13","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1349-7006.1995.tb03082.x","volume":"86","author":"N Goseki","year":"1995","unstructured":"Goseki N, Yamazaki S, Shimojyu K, Kando F, Maruyama M, Endo M, Koike M, Takahashi H (1995) Synergistic effect of methionine-depleting total parenteral nutrition with 5-fluorouracil on human gastric cancer: a randomized, prospective clinical trial. Jpn J Cancer Res 86:484\u2013489","journal-title":"Jpn J Cancer Res"},{"key":"9_CR14","first-page":"2583","volume":"58","author":"T Yoshioka","year":"1998","unstructured":"Yoshioka T, Wada T, Uchida N, Maki H, Yoshida H, Ide N, Kasai H, Hojo K, Shono K, Maekawa R, Yagi S, Hoffman RM, Sugita K (1998) Anticancer efficacy in vivo and in vitro, synergy with 5-fluorouracil, and safety of recombinant methioninase. Cancer Res 58:2583\u20132587","journal-title":"Cancer Res"},{"key":"9_CR15","first-page":"2157","volume":"5","author":"Y Tan","year":"1999","unstructured":"Tan Y, Sun X, Xu M, Tan X-Z, Sasson A, Rashidi B, Han Q, Tan X-Y, Wang X, An Z, Sun F-X, Hoffman RM (1999) Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice. Clin Cancer Res 5:2157\u20132163","journal-title":"Clin Cancer Res"},{"key":"9_CR16","first-page":"4017","volume":"61","author":"DM Kokkinakis","year":"2001","unstructured":"Kokkinakis DM, Hoffman RM, Frenkel EP, Wick JB, Han Q, Xu M, Tan Y, Schold SC (2001) Synergy between methionine stress and chemotherapy in the treatment of brain tumor xenografts in athymic mice. Cancer Res 61:4017\u20134023","journal-title":"Cancer Res"},{"key":"9_CR17","doi-asserted-by":"crossref","first-page":"35630","DOI":"10.18632\/oncotarget.15823","volume":"8","author":"T Murakami","year":"2017","unstructured":"Murakami T, Li S, Han Q, Tan Y, Kiyuna T, Igarashi K, Kawaguchi K, Hwang HK, Miyaki K, Singh AS, Nelson SD, Dry SM, Li Y, Hiroshima Y, Lwin TM, DeLong JC, Chishima T, Tanaka K, Bouvet M, Endo I, Eilber FC, Hoffman RM (2017) Recombinant methioninase effectively targets a Ewing\u2019s sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model. Oncotarget 8:35630\u201335638","journal-title":"Oncotarget"},{"key":"9_CR18","doi-asserted-by":"crossref","first-page":"85516","DOI":"10.18632\/oncotarget.20231","volume":"8","author":"K Kawaguchi","year":"2017","unstructured":"Kawaguchi K, Igarashi K, Li S, Han Q, Tan Y, Kiyuna T, Miyake Y, Murakami T, Chmielowski B, Nelson SD, Russell TA, Dry SM, Li Y, Unno M, Eilber FC, Hoffman RM (2017) Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma growth in a patient-derived orthotopic xenograft. Oncotarget 8:85516\u201385525","journal-title":"Oncotarget"},{"key":"9_CR19","doi-asserted-by":"crossref","first-page":"915","DOI":"10.18632\/oncotarget.23185","volume":"9","author":"K Kawaguchi","year":"2018","unstructured":"Kawaguchi K, Igarashi K, Li S, Han Q, Tan Y, Miyake K, Kiyuna T, Miyake M, Murakami T, Chmielowski S, Nelson SD, Russell TA, Dry SM, Li Y, Unno M, Eilber FC, Hoffman RM (2018) Recombinant methioninase (rMETase) is an effective therapeutic for BRAF-V600E-negative as well as -positive melanoma in patient-derived orthotopic xenograft (PDOX) mouse models. Oncotarget 9:915\u2013923","journal-title":"Oncotarget"},{"key":"9_CR20","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.canlet.2017.12.028","volume":"417","author":"K Igarashi","year":"2018","unstructured":"Igarashi K, Kawaguchi K, Li S, Han Q, Tan Y, Murakami T, Kiyuna T, Miyake K, Miyake M, Singh AS, Eckhadt MA, Nelson SD, Russell TA, Dry SM, Li Y, Yamamoto N, Hayashi K, Kimura H, Miwa S, Tsuchiya H, Singh RS, Eilber FC, Hoffman RM (2018) Recombinant methioninase in combination with DOX overcomes first-line DOX resistance in a patient-derived orthotopic xenograft nude-mouse model of undifferentiated spindle-cell sarcoma. Cancer Lett 417:168\u2013173","journal-title":"Cancer Lett"},{"key":"9_CR21","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1002\/jcb.26527","volume":"119","author":"K Igarashi","year":"2018","unstructured":"Igarashi K, Li S, Han Q, Tan Y, Kawaguchi K, Murakami T, Kiyuna T, Miyake K, Li Y, Nelson SD, Dry SM, Singh AS, Elliott I, Russell TA, Eckhadt MA, Yamamoto N, Hayashi K, Kimura H, Miwa S, Tsuchiya H, Eilber FC, Hoffman RM (2018) Growth of a doxorubicin-resistant undifferentiated spindle-cell sarcoma PDOX is arrested by metabolic targeting with recombinant methioninase. J Cell Biochem 119:3537\u20133544","journal-title":"J Cell Biochem"},{"key":"9_CR22","doi-asserted-by":"crossref","first-page":"11119","DOI":"10.18632\/oncotarget.24264","volume":"9","author":"K Kawaguchi","year":"2018","unstructured":"Kawaguchi K, Han Q, Li S, Tan Y, Igarashi K, Miyake K, Kiyuna T, Miyake M, Chmielowski B, Nelson SD, Russell TA, Dry SM, Li Y, Singh AS, Eckardt MA, Unno M, Eilber FC, Hoffman RM (2018) Intra-tumor L-methionine level highly correlates with tumor size in both pancreatic cancer and melanoma patient-derived orthotopic xenograft (PDOX) nude-mouse models. Oncotarget 9:11119\u201311125","journal-title":"Oncotarget"},{"key":"9_CR23","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1080\/15384101.2017.1405195","volume":"17","author":"K Kawaguchi","year":"2018","unstructured":"Kawaguchi K, Han Q, Li S, Tan Y, Igarashi K, Kiyuna T, Miyake K, Miyake M, Chmielowski B, Nelson SD, Russell TA, Dry SM, Li Y, Eckhardt MA, Unno M, Eilber FC, Hoffman RM (2018) Targeting methionine with oral recombinant methioninase (o-rMETase) arrests a patient-derived orthotopic xenograft (PDOX) model of BRAF-V600E mutant melanoma: implications for clinical cancer therapy and prevention. Cell Cycle 17:356\u2013361","journal-title":"Cell Cycle"},{"key":"9_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1517\/14712598.2015.963050","volume":"15","author":"RM Hoffman","year":"2015","unstructured":"Hoffman RM (2015) Development of recombinant methioninase to target the general cancer-specific metabolic defect of methionine dependence: a 40-year odyssey. Expert Opin Biol Ther 15:21\u201331","journal-title":"Expert Opin Biol Ther"},{"key":"9_CR25","doi-asserted-by":"publisher","first-page":"8729","DOI":"10.18632\/oncotarget.2369","volume":"5","author":"S Yano","year":"2014","unstructured":"Yano S, Li S, Han Q, Tan Y, Bouvet M, Fujiwara T, Hoffman RM (2014) Selective methioninase-induced trap of cancer cells in S\/G2 phase visualized by FUCCI imaging confers chemosensitivity. Oncotarget 5:8729\u20138736","journal-title":"Oncotarget"},{"key":"9_CR26","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1080\/15384101.2016.1181240","volume":"15","author":"S Yano","year":"2016","unstructured":"Yano S, Takehara K, Zhao M, Tan Y, Han Q, Li S, Bouvet M, Fujiwara T, Hoffman RM (2016) Tumor-specific cell-cycle decoy by Salmonella typhimurium A1-R combined with tumor-selective cell-cycle trap by methioninase overcome tumor intrinsic chemoresistance as visualized by FUCCI imaging. Cell Cycle 15:1715\u20131723","journal-title":"Cell Cycle"},{"key":"9_CR27","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1093\/jnci\/76.4.629","volume":"76","author":"PH Stern","year":"1986","unstructured":"Stern PH, Hoffman RM (1986) Enhanced in vitro selective toxicity of chemotherapeutic agents for human cancer cells based on a metabolic defect. J Natl Cancer Inst 76:629\u2013639","journal-title":"J Natl Cancer Inst"},{"key":"9_CR28","first-page":"5235","volume":"29","author":"E Thivat","year":"2009","unstructured":"Thivat E, Farges MC, Bacin F, D'Incan M, Mouret-Reynier MA, Cellarier E, Madelmont JC, Vasson MP, Chollet P, Durando X (2009) Phase II trial of the association of a methionine-free diet with cystemustine therapy in melanoma and glioma. Anticancer Res 29:5235\u20135240","journal-title":"Anticancer Res"},{"key":"9_CR29","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1002\/1097-0142(19901101)66:9<1873::AID-CNCR2820660904>3.0.CO;2-5","volume":"66","author":"C Jacquillat","year":"1990","unstructured":"Jacquillat C, Khayat D, Banzet P, Weil M, Fumoleau P, Avril MF, Namer M, Bonneterre J, Kerbrat P, Bonerandi JJ et al (1990) Final report of the French multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastases. Cancer 66:1873\u20131878","journal-title":"Cancer"},{"key":"9_CR30","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1053\/sonc.2002.35238","volume":"29","author":"E Bajetta","year":"2002","unstructured":"Bajetta E, Del Vecchio M, Bernard-Marty C, Vitali M, Buzzoni R, Rixe O, Nova P, Aglione S, Taillibert S, Khayat D (2002) Metastatic melanoma: chemotherapy. Semin Oncol 29:427\u2013445","journal-title":"Semin Oncol"},{"key":"9_CR31","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1097\/00019052-200012000-00002","volume":"13","author":"E Galanis","year":"2000","unstructured":"Galanis E, Buckner JC (2000) Chemotherapy of brain tumors. Curr Opin Neurol 13:619\u2013625","journal-title":"Curr Opin Neurol"},{"key":"9_CR32","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1097\/01.cad.0000176506.71304.ca","volume":"16","author":"E Thivat","year":"2005","unstructured":"Thivat E, Durando X, D'Incan M, Cure H, Mouret-Reynier MA, Madelmont JC, Souteyrand P, Chollet P (2005) Second-line chemotherapy of disseminated malignant melanoma with cystemustine at 60 mg\/m2: a phase II trial. Anticancer Drugs 16:1003\u20131007","journal-title":"Anticancer Drugs"},{"key":"9_CR33","first-page":"643","volume":"6","author":"F Poirson-Bichat","year":"2000","unstructured":"Poirson-Bichat F, Goncalves RA, Miccoli L, Dutrillaux B, Poupon MF (2000) Methionine depletion enhances the antitumoral efficacy of cytotoxic agents in drug-resistant human tumor xenografts. Clin Cancer Res 6:643\u2013653","journal-title":"Clin Cancer Res"},{"key":"9_CR34","first-page":"3822","volume":"2002","author":"D Morvan","year":"2002","unstructured":"Morvan D, Papon J, Madelmont JC, Demidem A (2002) Methionine deprivation potentiates the effect of cystemustine treatment on B16 melanoma tumor in syngenic recipients. AACR Proc 2002:3822","journal-title":"AACR Proc"},{"key":"9_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/01635580701525877","volume":"60","author":"X Durando","year":"2008","unstructured":"Durando X, Thivat E, Farges MC, Cellarier E, D'Incan M, Demidem A, Vasson MP, Barthomeuf C, Chollet P (2008) Optimal methionine-free diet duration for nitrosourea treatment: a phase I clinical trial. Nutr Cancer 60:23\u201330","journal-title":"Nutr Cancer"},{"key":"9_CR36","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1207\/S15327914NC422_2","volume":"42","author":"DE Epner","year":"2002","unstructured":"Epner DE, Morrow S, Wilcox M, Houghton JL (2002) Nutrient intake and nutritional indexes in adults with metastatic cancer on a phase I clinical trial of dietary methionine restriction. Nutr Cancer 42:158\u2013166","journal-title":"Nutr Cancer"},{"key":"9_CR37","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000313700","volume":"78","author":"X Durando","year":"2010","unstructured":"Durando X, Farges MC, Buc E, Abrial C, Petorin-Lesens C, Gillet B, Vasson MP, Pezet D, Chollet P, Thivat E (2010) Dietary methionine restriction with FOLFOX regimen as first line therapy of metastatic colorectal cancer: a feasibility study. Oncology 78:205\u2013209","journal-title":"Oncology"},{"key":"9_CR38","first-page":"1069","volume":"63","author":"W Kreis","year":"1979","unstructured":"Kreis W (1979) Tumor therapy by depriving of 1-methionine: rationale and results. Cancer Treat Rep 63:1069\u20131072","journal-title":"Cancer Treat Rep"},{"key":"9_CR39","first-page":"19","volume":"1","author":"Y Shimozato","year":"1971","unstructured":"Shimozato Y, Oboshi S, Baba E (1971) Histopathological evaluation of effects of radiotherapy and chemotherapy for carcinomas. Jpn J Clin Oncol 1:19\u201335","journal-title":"Jpn J Clin Oncol"},{"key":"9_CR40","first-page":"429","volume":"28","author":"Y Wada","year":"1993","unstructured":"Wada Y, Kando F, Shimojyu K, Aoi C, Goseki N, Okabe S, Sunagawa M, Endo M (1993) Effects of pre-operative methionine-depleting total parenteral nutrition (RT-therapy) on gastric carcinoma \u2014 pathological study in two gastrectomized cases. J Jpn Soc Cancer Ther 28:429","journal-title":"J Jpn Soc Cancer Ther"}],"container-title":["Methods in Molecular Biology","Methionine Dependence of Cancer and Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-8796-2_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T22:13:28Z","timestamp":1606428808000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-8796-2_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9781493987955","9781493987962"],"references-count":40,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-8796-2_9","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"7 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}